Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 135 for colorectal

Edit search filters
  1. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

    Scottsdale/Phoenix, AZ

  2. A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Phase 1b, Multicenter, Randomized, Blinded, Placebo-controlled Study to Evaluate the Efficacy of Guselkumab in Subjects with Familial Adenomatous Polyposis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. Gemini Study to Evaluate the Integration of Cancer Genetic Testing into a Cancer Clinical Practice at Mayo Clinic at Arizona

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. A Study to Evaluate Exercise for Cancer Patients at Risk of Falling

    Rochester, MN

  6. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study to Evaluate a Multi-target Stool DNA Test, Cologuard, for Colorectal Cancer (CRC) Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer

    Rochester, MN

  8. A Study to Assess a New Personalized Tool for Colorectal Cancer Peritoneal Disease Treatment

    Rochester, MN

  9. Patient Outcomes after Hepatic Artery Infusion Pump Placement

    Rochester, MN

  10. A Study to Validate An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test for Colorectal Cancer Screening

    Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer